Divi's Laboratories Price Change Analysis
-
P/E Ratio
59.2
-
PEG Ratio
1.2
-
Market Cap Cr
113341.8
-
Price to Book Ratio
372.9
-
EPS
73.7
-
Dividend
1000 ()
-
Relative Strength Index
50.16
-
Money Flow Index
53.17
-
MACD Signal
-34.95
-
Average True Range
126.34
Investment Ratings
-
Master Rating:
-
EPS Strength
Price Strength
Buyer Demand
Group Rank
Result Highlights
Divi's Laboratories Synopsis
NSE-Medical-Generic Drugs
Divi's Lab is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 6798.61 Cr. and Equity Capital is Rs. 53.09 Cr. for the Year ended 31/03/2021. Divi's Laboratories Ltd. is a Public Limited Listed company incorporated on 12/10/1990 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24110TG1990PLC011854 and registration number is 011854.-
Market Cap
111,998.30
-
Sales
8,103.18
-
Shares in Float
-
No of Funds
808
-
Yield
0.46
-
Book Value
12.5
-
U/D Vol Ratio
1
-
LTDebt/Equity
-
Alpha
0.01
-
Beta
0.83
| Owner Name | Jun-21 |
|---|---|
| Promoters | 51.95% |
| Mutual Funds | 12.61% |
| Foreign Portfolio Investors | 20.6% |
| Financial Institutions/ Banks | 0% |
| Individual Investors | 8.81% |
| Others | 6.03% |
| Name | Designation |
|---|---|
| Dr. Ramesh B V Nimmagadda | Non Exe.Chairman&Ind.Director |
| Dr. Murali K Divi | Managing Director |
| Mr. Madhusudana Rao Divi | Whole Time Director |
| Dr. Kiran S Divi | WholeTime Director & CEO |
| Ms. Nilima Prasad Divi | Whole Time Director |
| Mr. N V Ramana | Executive Director |
| Mr. K V K Seshavataram | Independent Director |
| Dr. G Suresh Kumar | Independent Director |
| Mr. R Ranga Rao | Independent Director |
| Dr. S Ganapaty | Independent Director |
| Prof. Sunaina Singh | Independent Director |
| Mr. K V Chowdary | Independent Director |
Divi's Laboratories Forecast
Price Estimates
Eps And Sales Estimates
Divi's Laboratories Financials
- Quarterly P&L
- Annual P&L
- Cash Flow
- Balance Sheet
- Ratios
Divi's Laboratories Technicals
EMA & SMA
CURRENT PRICE
EMA
Divi's Laboratories Resistance and Support
Divi's Laboratories Delivery and Volume
Divi's Laboratories Price Change Analysis
Corporate Action
Similar Stocks
| Company Name | 52 Week () |
Market Price () | Volume |
|---|
Videos
About Company
News
FAQs
Divis Laboratories Ltd is an active pharmaceutical ingredient (API) and intermediates company situated in India. Divis Laboratories specialises in the production of leading generic chemicals, nutraceutical components, and custom API and intermediate synthesis for worldwide innovators.
Divis Laboratories has an operating revenue of INR 7,437.78 Cr. on a trailing 12-month basis. Annual revenue growth of 26% is outstanding, Pre-tax margin of 38% is great, ROE of 21% is exceptional. Institutional holding in Divis Laboratories has gone up in the last reported quarter is a positive sign. As per analysts rating in the last 6 months, the recommendation is to HOLD Divis Laboratories.
Divis Laboratories is debt-free and has a strong balance sheet enabling it to report stable earnings growth across business cycles.
Murali Divi is the founder of Divis Laboratories, one of the top three manufacturers of active pharmaceutical ingredients (API).
Divi's Laboratories share price is